Peptide therapy claims on TikTok: what the science actually supports

What did @glowjerah.peptides actually say?

The transcript here is a challenge. Large portions appear to be in Filipino (Tagalog), and the auto-transcription produced a garbled mix of phonetic guesses and partial English. What we can piece together: the creator is demonstrating a GHK-Cu (copper peptide) application using microneedling, specifying a 31-gauge needle and 6mm depth, and is sharing this as a personal experience, not medical advice. They close by saying "I'm not a medical professional, I'm just sharing my experience" and direct viewers to a peptide source linked in their bio.

That last part matters. Linking to a commercial peptide vendor while narrating an injection tutorial to 200K+ viewers sits in a gray zone regardless of how many disclaimers get added at the end. We can only fact-check what we can confirm was said, so we'll focus on GHK-Cu topical and injectable use, microneedling administration, and the vendor-linking behavior.

Does the science back this up?

GHK-Cu is one of the more research-supported peptides in the cosmetic and wound-healing space, but "more supported than most" is not the same as "well-established clinical evidence." The bar is low in peptide research.

GHK (glycyl-L-histidyl-L-lysine) is a naturally occurring copper-binding tripeptide first isolated from human plasma by Pickart in 1973. It has genuine mechanistic plausibility: studies show it activates TGF-beta pathways, stimulates collagen and glycosaminoglycan synthesis, and has antioxidant and anti-inflammatory effects in cell culture (Pickart et al., 2015, Journal of Aging Research). A 2018 review by Dou et al. in Biomedical Reports confirmed these wound-healing signals in animal models. The problem is that rigorous human RCTs are sparse. Most cited human data comes from small cosmetic trials funded by companies selling GHK-Cu products, which is exactly the kind of conflict of interest that should make you skeptical.

Combining GHK-Cu with microneedling has a logical basis: microneedling creates micro-channels that improve transdermal absorption of topical agents. A 2020 paper by Aust et al. in Skin Pharmacology and Physiology noted enhanced peptide penetration via microneedling. But 6mm needle depth, mentioned in the transcript, is aggressive for facial application and approaches subcutaneous tissue, well beyond what most dermatologists use for topical delivery purposes.

What did they get wrong (or right)?

Credit where it's due: GHK-Cu is one of the few peptides with actual mechanistic research behind it, and the creator's disclaimer that they are not a medical professional is at least present. Those are two things many peptide influencers skip entirely.

What's problematic: a 6mm needle depth for facial microneedling is outside standard cosmetic practice. Clinical microneedling for collagen induction typically uses 0.5mm to 2.5mm depths depending on the treatment area. Six millimeters risks hitting subcutaneous fat, nerves, or facial vasculature, particularly in thinner facial regions. No context is given about what body area this is being applied to, which matters enormously for depth safety.

The vendor link in the bio is a separate concern. Recommending a specific peptide source to a large audience without disclosing financial relationships, and without that source being a licensed compounding pharmacy with verifiable quality testing, raises real purity and safety questions. Unregulated peptide vendors frequently sell products with incorrect concentrations, contamination, or unlisted fillers (Cohen et al., 2022, JAMA Internal Medicine).

The instruction-style framing, even in another language, combined with a commercial link, is the kind of content that regulators and platforms are increasingly scrutinizing.

What should you actually know?

GHK-Cu has legitimate scientific interest. It is not a proven treatment for any medical condition. The cosmetic signal, particularly for wound healing and skin texture, is real but preliminary. Human trial data is thin, and most of what exists comes from industry-adjacent sources.

If you are considering GHK-Cu, the safest and most evidence-adjacent route is topical application, not self-injection or deep microneedling at home. Any microneedling beyond superficial depths should be done by a licensed provider who can assess your anatomy, use sterile technique, and manage complications.

Sourcing matters more than most peptide content creators acknowledge. Peptides purchased from online vendors lack FDA oversight for purity, sterility, or accurate concentration. A 2021 analysis by Meijer et al. in Drug Testing and Analysis found significant concentration discrepancies in commercially available research peptides. If you are working with a telehealth provider who prescribes compounded peptides, that compounding pharmacy must be 503A or 503B accredited for any reasonable quality assurance.

Finally, "I'm not a medical professional" at the end of an instructional video about needle depth and peptide sourcing does not transfer liability. It does not protect viewers from harm. If you are making decisions based on TikTok tutorials, build in a consult with someone who can actually evaluate your individual situation.